FIRST LIGHT ACQU(FLAG) - Prospectus(update)

Washington, D.C. 20549 As filed with the Securities and Exchange Commission on April 2, 2024. Registration No. 333-276741 UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Allan J. Camaisa Chief Executive Officer c/o Calidi Biotherapeutics, Inc. 4475 Executive Drive, Suite 200, San Diego, CA 92121 Telephone: (858) 794-9600 (Name, address, including zip code, and telephone number, including ar ...